1,2-Dimethylhydrazine-induced alterations in lipid peroxidation in preneoplastic and neoplastic colonic tissues.
To determine whether alterations in lipid peroxidation existed in the preneoplastic and neoplastic colonic tissues of animals treated with the procarcinogen 1,2-dimethylhydrazine, rats were injected subcutaneously with this agent (20 mg/kg body weight per week) or diluent for 5, 10, 15 and 26 weeks. At each of these time periods, animals from both groups were sacrificed, their distal colonic mucosa and/or tumors harvested, and examined and compared with respect to malondialdehyde and lipofuscin-like pigments levels. Additionally, at 26 weeks, the fatty acid composition of microsomes prepared from control, 'uninvolved' and tumor colonic tissues were analyzed and compared. The results of these experiments demonstrated that: (1) the levels of these products of lipid peroxidation were similar in the distal colons of all animals at 5 and 10 weeks; (2) at 15 weeks, however, lipid peroxidation was decreased in the distal colons of animals treated with dimethylhydrazine; (3) at 26 weeks, the levels of these products of lipid peroxidation remained lower in dimethylhydrazine-treated distal 'uninvolved' colonic mucosa and was, moreover, markedly decreased in colonic tumors; and (4) at this latter time period, differences in the fatty acid composition between tumor, 'uninvolved' and control tissues were found. These differences, however, did not appear to underlie the changes noted in the lipid peroxidation products seen in these tissues. Taken together, these findings suggest that alterations in lipid peroxidation may be involved in the colonic malignant transformation process in this experimental model.
Dudeja
P K
PK
Department of Medicine, Pritzker School of Medicine, University of Chicago, IL.
Brasitus
T A
TA
D019813:1,2-Dimethylhydrazine; D000818:Animals; D003106:Colon / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000378:metabolism; D004127:Dimethylhydrazines / Q000633:toxicity*; D005227:Fatty Acids / Q000378:metabolism; D007413:Intestinal Mucosa / Q000187:drug effects; D015227:Lipid Peroxidation / Q000187:drug effects; D008062:Lipofuscin / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008861:Microsomes / Q000187:drug effects; D011230:Precancerous Conditions / Q000378:metabolism*; D051381:Rats
D004127:Dimethylhydrazines; D005227:Fatty Acids; D008062:Lipofuscin; D008315:Malondialdehyde; D019813:1,2-Dimethylhydrazine